Journal of Drug Assessment
Volume 10, 2021 - Issue 1
Open access
1,513
Views
1
CrossRef citations to date
0
Altmetric
Neurology
Real-world experience of ocrelizumab in multiple sclerosis in an Arab population
Beatriz Garcia-Cañibanoa Department of Neurology, Neuroscience Institute, Hamad Medical Corporation, Doha, Qatar;b Weill Cornell Medical College, Doha, QatarCorrespondence[email protected]
, Sami Ouanesc Department of Psychiatry, Hamad Medical Corporation, Doha, Qatar
, Gowrii Saswathy Ganesanb Weill Cornell Medical College, Doha, Qatarhttps://orcid.org/0000-0002-9039-8387
, Wajiha Yousufb Weill Cornell Medical College, Doha, Qatar
, Basel Humosb Weill Cornell Medical College, Doha, Qatar
, Tehniyat Baigb Weill Cornell Medical College, Doha, Qatar
, Faiza Ibrahimd Clinical Services Unit, Hamad Medical Corporation, Doha, Qatar
, Rajvir Singhe Cardiology Research Center, Heart Hospital, Hamad Medical Corporation, Doha, Qatar
& Dirk Deleua Department of Neurology, Neuroscience Institute, Hamad Medical Corporation, Doha, Qatar;b Weill Cornell Medical College, Doha, Qatar
show all
Pages 106-113
|
Received 27 Apr 2021, Accepted 01 Oct 2021, Published online: 19 Oct 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.